1-20 of 35
Stefania Oliva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Not Eligible or with No Immediate Intent for Transplant: Long-Term Efficacy and Safety in a Phase 1b Study

Enrique M Ocio, Aurore Perrot, Pierre Bories, Jesús F. San-Miguel, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Maria-Victoria Mateos, Paula Rodríguez-Otero, Stefania Oliva, Axel Nogai, Bruno Paiva, Yi Li, Eric Le Bras, Sandrine Macé, Ercem Kodas, Helgi Van de Velde, Philippe Moreau
Journal: Blood
Blood (2024) 144 (Supplement 1): 1976.
https://doi.org/10.1182/blood-2024-200135
Published: 2024
Journal Articles

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

Clinical Trials & Observations Brief Report
Mattia D’Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Paolo Corradini, Stefania Oliva, Antonio Ledda, Mariella Grasso, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Stelvio Ballanti, Cristina Velluti, Claudia Cellini, Alessandro Gozzetti, Angelo D. Palmas, Barbara Gamberi, Katia Mancuso, Laura Paris, Renato Zambello, Maria Teresa Petrucci, Benedetto Bruno, Pellegrino Musto, Francesca Gay
Journal: Blood
Blood (2024) 143 (7): 592–596.
https://doi.org/10.1182/blood.2023022080
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of Daratumumab on Hematopoietic Stem Cell Mobilization with G-CSF and on-Demand Plerixafor in Newly-Diagnosed Multiple Myeloma Patients

Roberto Mina, Bruno Garibaldi, Giuseppe Bertuglia, Andrea Casson, Barbara Sarina, Francesca Gay, Silvio Mercadante, Jacopo Mariotti, Mattia D'Agostino, Daniela Taurino, Stefania Oliva, Alessandra Larocca, Daniele Mannina, Chiara De Philippis, Giulia Benevolo, Tiziana Francisci, Marco Lorenzi, Benedetto Bruno, Armando Santoro, Sara Bringhen, Stefania Bramanti
Journal: Blood
Blood (2023) 142 (Supplement 1): 6633.
https://doi.org/10.1182/blood-2023-180082
Published: 2023
Journal Articles

Genomic and Immune Determinants of Resistance to Anti-CD38 MoAb Based Therapy in Relapsed Multiple Myeloma

Bachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Benjamin Diamond, Niccolò Bolli, Paolo Corradini, David Coffey, Ola Landgren, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
Journal: Blood
Blood (2023) 142 (Supplement 1): 1966.
https://doi.org/10.1182/blood-2023-182301
Published: 2023
Journal Articles

The Use of Next Generation Flow in Multiple Myeloma Patients: A Preliminary Real-Life Multicenter MRD Harmonization Experience

Stefania Oliva, Elona Saraci, Valentina Trimarco, Marco Chiarini, Nunziatina Laura Parrinello, Renato Zambello, Iole Cordone, Tania Villanova, Serena Masi, Giovanni Rossi, Sara Marino, Anna Maria Triolo, Aldo Roccaro, Angelo Michele Carella, Francesco Buccisano, Angelo Belotti, Maria Irno Consalvo, Alessandra Romano, Alessia Tonini, Silvio Mercadante, Benedetto Bruno, Carolina Terragna, Elena Zamagni
Journal: Blood
Blood (2023) 142 (Supplement 1): 7161.
https://doi.org/10.1182/blood-2023-186536
Published: 2023
Journal Articles

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Clinical Trials & Observations
Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee Yong, Vania Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksac, Katja Weisel, Kenneth C. Anderson, María-Victoria Mateos, Philippe Moreau, Jesus San-Miguel, Nikhil C. Munshi, Hervé Avet-Loiseau
Journal: Blood
Blood (2020) 136 (26): 3033–3040.
https://doi.org/10.1182/blood.2020008150
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial

Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, MD, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas, Agostina Siniscalchi, Ilan R. Kirsch, Paolo Corradini, Pellegrino Musto, Mario Boccadoro, Elena Zamagni, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-137351
Published: 2020
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling

Martin H Van Vliet, Yan-Ting Chen, PhD, Erik H Van Beers, PhD, Rowan Kuiper, PhD, Erik T. Valent, PhD, Marieke Spaan, MSc, Carolina Terragna, Elena Zamagni, Michele Cavo, Stefania Oliva, Alessandra Larocca, Torsten Haferlach, MD, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Anders Waage, MD PhD, M Duin, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-137389
Published: 2020
Journal Articles

Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity

Luca Bertamini, MD, Mariella Grasso, Mattia D'Agostino, MD, Anna Pascarella, Patrizia Tosi, Federico Monaco, Francesco Pisani, Paola Bertazzoni, Milena Gilestro, Andrea Capra, Piero Galieni, Ombretta Annibali, Vincenzo Pavone, Stefano Molica, MD, Sonia Ronconi, Paola Tacchetti, Pellegrino Musto, Francesca Gay, MD, Mario Boccadoro, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137075
Published: 2020
Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, MD, Cristina Nanni, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Paola Omedé, Rossella Ribolla, MD, Monica Galli, Manuela Racca, Renato Zambello, Barbara Gamberi, MD, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Tonino Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, Prof, MD PhD, Mario Boccadoro, Michele Cavo, Stefania Oliva
Journal: Blood
Blood (2019) 134 (Supplement_1): 4321.
https://doi.org/10.1182/blood-2019-125134
Published: 2019
Journal Articles

Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma Patients

Stefania Oliva, Elisa Genuardi, Angelo Belotti, Pio Manlio Mirko Frascione, Monica Galli, Andrea Capra, Massimo Offidani, Federico Vozella, Renato Zambello, Daniel Auclair, Agostina Siniscalchi, Jennifer Yesil, Ombretta Annibali, Ilan M. Kirsch, Simona Caltagirone, Allison P. Jacob, Stelvio Ballanti, Angelo D. Palmas, Antonio Ledda, Paolo Corradini, Paola Omedé, Michele Cavo, Pellegrino Musto, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4322.
https://doi.org/10.1182/blood-2019-124645
Published: 2019
Journal Articles

Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis

Paolo Milani, MD PhD, Francesca Fazio, MD, Marco Basset, MD, Tamara Berno, MD, Alessandra Larocca, Andrea Foli, MD, Marcello Riva, MD, Stefania Oliva, Jessica Ripepi, Mario Nuvolone, MD PhD, Maria Teresa Petrucci, Giampaolo Merlini, MD, Giovanni Palladini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1860.
https://doi.org/10.1182/blood-2019-130675
Published: 2019
Journal Articles

Preliminary Results from a Phase I Study of Isatuximab (ISA) in Combination with Bortezomib, Lenalidomide, Dexamethasone (VRd), and in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Non-Eligible for Transplant

Enrique M. Ocio, MD, Paula Rodriguez Otero, MD, Sara Bringhen, MD, Stefania Oliva, Axel Nogai, MD, Michel Attal, MD PhD, Philippe Moreau, Dheepak Kanagavel, Thomas F Fitzmaurice, PhD, Junlong Wu, Joaquin Martinez Lopez, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 595.
https://doi.org/10.1182/blood-2018-99-111244
Published: 2018
Journal Articles

A Phase Ib Study of Isatuximab in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone (VCDI) in Patients with Newly Diagnosed Multiple Myeloma Non-Eligible for Transplantation

Enrique M. Ocio, MDPhD, Sara Bringhen, MD, Stefania Oliva, MD, Paula Rodriguez-Otero, MD PhD, Dheepak Kanagavel, MD PhD, Corina Oprea, MD, Vivian Wei, Severine Doroumian, Joaquin Martinez-Lopez, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3160.
https://doi.org/10.1182/blood.V130.Suppl_1.3160.3160
Published: 2017
Journal Articles

Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study

Michele Cavo, MD, Roman Hájek, MD, Lucia Pantani, MD, Meral Beksac, MD, Stefania Oliva, MD, Luca Dozza, Hans Erik Johnsen, MD Professor, Maria Teresa Petrucci, MD, Ulf-Henrik Mellqvist, MD, Concetta Conticello, MD, Christoph Driessen, MD, Giulia Marzocchi, BSc, Meletios A. Dimopoulos, Sonja Zweegman, MD PhD, Ka Lung Wu, MD, Barbara Gamberi, MD, Claudia Crippa, MD, Bronno van der Holt, Massimo Offidani, MD, Ruth Wester, Iolanda Donatella Vincelli, MD, Rossella Troia, Petra Cornelisse, Mario Boccadoro, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 397.
https://doi.org/10.1182/blood.V130.Suppl_1.397.397
Published: 2017
Journal Articles

A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard-Risk Patients

Francesca Maria Gay, Delia Rota Scalabrini, MD, Angelo Belotti, MD, Monica Galli, MD PhD, Elena Zamagni, MD, Massimo Offidani, MD, Stefania Oliva, MD, Vittorio Montefusco, MD, Renato Zambello, MD, Antonio Ledda, MD, Mariella Grasso, MD, Sara Aquino, MD, Fabrizio Esma, Patrizia Tosi, MD, Francesco Pisani, MD, Ombretta Annibali, Anna Marina Liberati, Anna Baraldi, MD, Piero Galieni, MD, Giorgina Specchia, MD, Norbert Pescosta, MD, Katia Mancuso, MD, Laura Paris, MD, Rossella Ribolla, MD, Valentina Coha, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 4541.
https://doi.org/10.1182/blood.V130.Suppl_1.4541.4541
Published: 2017
Journal Articles

PAK4 Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldestrostom Macroglobulinemia

Na Li, MD, Mariateresa Fulciniti, PhD, Michael A Lopez, BS, Tommaso Perini, MD, Raphael Szalat, MD, Subodh Kumar, PhD, Mehmet Kemal Samur, PhD, Lian Xu, Yan Xu, MD, William Senapedis, PhD, Erkan Baloglu, Stefania Oliva, MD, Masood A. Shammas, PhD, Zachary Hunter, PhD, Kenneth C Anderson, MD, Steven P Treon, MDPhDFRCP, Nikhil Munshi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 648.
https://doi.org/10.1182/blood.V130.Suppl_1.648.648
Published: 2017
Journal Articles

Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma

Mariateresa Fulciniti, Joaquin Martinez-Lopez, William Senapedis, Stefania Oliva, Rajya Lakshmi Bandi, Nicola Amodio, Yan Xu, Raphael Szalat, Annamaria Gulla, Mehmet K. Samur, Aldo Roccaro, Maria Linares, Michele Cea, Erkan Baloglu, Christian Argueta, Yosef Landesman, Sharon Shacham, Siyuan Liu, Monica Schenone, Shiaw-Lin Wu, Barry Karger, Rao Prabhala, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Blood
Blood (2017) 129 (16): 2233–2245.
https://doi.org/10.1182/blood-2016-06-724831
Published: 2017
Includes: Supplemental data
Journal Articles

p21-Associated Kinase 4 (PAK4) Addiction in Multiple Myeloma: A Potential Therapeutic Application with Enhanced Activity in FGFR3 Expressing Myeloma

Mariateresa Fulciniti, PhD, Joaquin Martinez Lopez, MD PhD, William Senapedis, PhD, Stefania Oliva, MD, Raphaël Szalat, MD, Mehmet K. Samur, PhD, Rao H Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C Munshi, MD
Journal: Blood
Blood (2016) 128 (22): 3302.
https://doi.org/10.1182/blood.V128.22.3302.3302
Published: 2016